Eculizumab as first line treatment for patients with severe presentation of Complement Factor H antibodies mediated Hemolytic Uremic Syndrome
Preprint in Research Square (June 2024)
The most recent citing publications are shown below. View all 47 publications that cite this research output on Dimensions.
Preprint in Research Square (June 2024)
Article in BMC Nephrology (May 2024)
Article in Pediatric Nephrology (April 2024)